SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Melissa E. Laird, Amira Mohsen, Darragh Duffy, Rasha Mamdouh, Lenaig LeFouler, Armanda Casrouge, Mai El-Daly, Mona Rafik, Mohamed Abdel-Hamid, Alexandre Soulier, Jean-Michel Pawlotsky, Christophe Hézode, Isabelle Rosa, Philippe Renard, Mostafa K. Mohamed, Philippe Bonnard, Jacques Izopet, Vincent Mallet, Stanislas Pol, Matthew L. Albert, Arnaud Fontanet, Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection, Journal of Hepatology, 2014,

    CrossRef

  2. 2
    Fernando Manuel Jiménez Macías, Fátima Barrero Alor, Pedro Germán Casado Monge, Manuel Ramos Lora, Emilio Pujol de la Llave, Carlos Ruíz-Frutos, Cinética lipídica en el tratamiento antiviral dual en pacientes con hepatitis crónica C, Medicina Clínica, 2014,

    CrossRef

  3. 3
    Hiroshi Abe, Akihito Tsubota, Noritomo Shimada, Masanori Atsukawa, Keizo Kato, Koichi Takaguchi, Toru Asano, Yoshimichi Chuganji, Choitsu Sakamoto, Hidenori Toyoda, Takashi Kumada, Tatsuya Ide, Michio Sata, Yoshio Aizawa, Factors associated with sustained virological response in 24-week telaprevir-based triple therapy for chronic hepatitis C genotype 1b patients with the IL28B minor genotype, Hepatology Research, 2014, 44, 8
  4. 4
    Eiichi Ogawa, Norihiro Furusyo, Eiji Kajiwara, Hideyuki Nomura, Kazufumi Dohmen, Kazuhiro Takahashi, Makoto Nakamuta, Takeaki Satoh, Koichi Azuma, Akira Kawano, Yuichi Tanabe, Kazuhiro Kotoh, Shinji Shimoda, Jun Hayashi, Influence of low-density lipoprotein cholesterol on virological response to telaprevir-based triple therapy for chronic HCV genotype 1b infection, Antiviral Research, 2014, 104, 102

    CrossRef

  5. 5
    David H. Van Thiel, Magdalena George, Bashar M. Attar, Giuliano Ramadori, Niculae Ion-Nedelcu, Plasma Triglyceride Levels May Modulate Hepatitis C Viral Replication, Digestive Diseases and Sciences, 2014, 59, 4, 881

    CrossRef

  6. 6
    George N. Ioannou, Lauren A. Beste, Pamela K. Green, Similar Effectiveness of Boceprevir and Telaprevir Treatment Regimens for Hepatitis C Virus Infection on the Basis of a Nationwide Study of Veterans, Clinical Gastroenterology and Hepatology, 2014, 12, 8, 1371

    CrossRef

  7. 7
    Martin T. Ferris, Mark T. Heise, 2014,

    CrossRef

  8. 8
    T. Bader, L. D. Hughes, J. Fazili, B. Frost, M. Dunnam, A. Gonterman, M. Madhoun, C. E. Aston, A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naïve genotype 1 hepatitis C patients, Journal of Viral Hepatitis, 2013, 20, 9
  9. 9
    Miłosz Parczewski, Genomics and transcriptomics in HIV and HIV/HCV coinfection—Review of basic concepts and genome-wide association studies, HIV & AIDS Review, 2013, 12, 4, 97

    CrossRef

  10. 10
    David A. Sheridan, R. Dermot G. Neely, Margaret F. Bassendine, Hepatitis C virus and lipids in the era of direct acting antivirals (DAAs), Clinics and Research in Hepatology and Gastroenterology, 2013, 37, 1, 10

    CrossRef

  11. 11
    Melanie E. Garrett, Manal F. Abdelmalek, Allison Ashley-Koch, Michael A. Hauser, Cynthia A. Moylan, Herbert Pang, Anna Mae Diehl, Hans L. Tillmann, IL28B rs12979860 is not associated with histologic features of NAFLD in a cohort of Caucasian North American patients, Journal of Hepatology, 2013, 58, 2, 402

    CrossRef

  12. You have free access to this content12
    J. A. del Campo, J. Ampuero, L. Rojas, M. Conde, Á. Rojas, M. Maraver, R. Millán, M. García-Valdecasas, J. R. García-Lozano, M. F. González-Escribano, M. Romero-Gómez, Insulin resistance predicts sustained virological response to treatment of chronic hepatitis C independently of the IL28b rs12979860 polymorphism, Alimentary Pharmacology & Therapeutics, 2013, 37, 1
  13. 13
    W.-K. Seto, O. T.-Y. Tsang, K. Liu, J. M.-C. Chan, D. K.-H. Wong, J. Fung, C.-L. Lai, M.-F. Yuen, Role of IL28B and inosine triphosphatase polymorphisms in the treatment of chronic hepatitis C virus genotype 6 infection, Journal of Viral Hepatitis, 2013, 20, 7
  14. 14
    Yoshio Aizawa, Noritomo Shimada, Hiroshi Abe, Nobuyoshi Seki, Yuta Aida, Haruya Ishiguro, Makiko Ika, Keizo Kato, Akihito Tsubota, Serum Lipoprotein Profiles and Response to Pegylated Interferon Plus Ribavirin Combination Therapy in Patients With Chronic HCV Genotype 1b Infection, Hepatitis Monthly, 2013, 13, 5

    CrossRef

  15. 15
    Tatsuo Miyamura, Tatsuo Kanda, Shingo Nakamoto, Shuang Wu, Xia Jiang, Makoto Arai, Keiichi Fujiwara, Fumio Imazeki, Osamu Yokosuka, Roles of ITPA and IL28B Genotypes in Chronic Hepatitis C Patients Treated with Peginterferon Plus Ribavirin, Viruses, 2012, 4, 12, 1264

    CrossRef

  16. You have free access to this content16
    Alessio Aghemo, Gian Maria Prati, Maria Grazia Rumi, Roberta Soffredini, Roberta D'Ambrosio, Emanuela Orsi, Stella De Nicola, Elisabetta Degasperi, Valeria Grancini, Massimo Colombo, Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C, Hepatology, 2012, 56, 5